Canine Immune-Mediated Skin Disease Study Guide

Overview and Clinical Importance

Immune-mediated skin diseases (IMSDs) represent a group of conditions in which the body's immune system inappropriately targets components of the skin. These diseases occur when autoantibodies attack structural proteins of the epidermis (pemphigus), the basement membrane zone (subepidermal blistering diseases), or components at the dermoepidermal junction (lupus erythematosus). While individually uncommon, these conditions represent significant board examination topics because they require systematic diagnostic approaches, careful histopathological interpretation, and complex long-term immunosuppressive management.

Understanding the pathophysiology, clinical presentation, and treatment of these diseases is essential for the NAVLE. Key concepts include recognizing the characteristic lesion distributions, understanding which diagnostic tests to pursue, and knowing when to initiate immunosuppressive therapy versus treating for more common conditions like bacterial pyoderma.

Section 1: The Pemphigus Complex

The pemphigus complex is a group of autoimmune dermatoses characterized by acantholysis - the loss of intercellular adhesion between keratinocytes caused by autoantibodies targeting desmosomal proteins. The level of acantholysis within the epidermis determines the specific pemphigus variant and correlates with clinical severity.